GlucoTrack, Inc. - Common Stock (GCTK)
Healthcare › Surgical & Medical Instruments & Apparatus
Investment Snapshot
- Trading 94% below Graham Number ($29.54) — significant margin of safety
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -737.2%
GlucoTrack, Inc. - Common Stock (GCTK) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $3 million . Key value metrics: P/E ratio 0.1, P/B ratio 1.19, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
GlucoTrack, Inc. - Common Stock — Fundamental Analysis Summary
GlucoTrack, Inc. - Common Stock (GCTK) is trading 94% below its Graham Number of $29.54 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 0.1x.
On financial health, GCTK shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -737.2% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 2.01.
StockPik's composite Value Score for GCTK is 43/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
GCTK shows earnings growing at 14%.